Ultime notizie per Conn's (OTC:CONNQ) Azioni

Conn's Inc is a us-based specialty retailer selling durable consumer goods and related services. The company operates through two segments: retail and credit. The retail segment sells furniture, home appliances, electronics, and more. The credit segment provides credit solutions for credit-constrained consumers. They focus on the us market and offer competitive prices, affordable payment options, and fast delivery and installation. Conn's Inc primarily focuses on the us market and generates its revenue from the retail segment. They offer customers the opportunity to compare prices across brands with confidence, along with affordable monthly payment options, fast delivery and installation in the majority of their markets, and product repair services.

Conn's Inc

Earnings

News

BSLK

Bolt Projects Holdings Q3 EPS $0.32

WIIM

UPLD

Upland Software shares are trading higher after the company reported better-than-expected Q3 adjusted EPS results.

Golden Entertainment (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GDEN#NASDAQ">GDEN</a>) reported quarterly earnings of $0.18 per share which beat the analyst consensus estimate of $0.10 by 80 percent. This is a 200 percent increase over earnings of $0.06 per share from the same period last year. The company reported quarterly sales of $161.23 million which missed the analyst consensus estimate of $162.25 million by 0.63 percent. This is a 37.44 percent decrease over sales of $257.73 million the same period last year.

Earnings Beats

Earnings Misses

GDEN

Golden Entertainment Q3 EPS $0.18 Beats $0.10 Estimate, Sales $161.23M Miss $162.25M Estimate

aTyr Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATYR#NASDAQ">ATYR</a>) reported quarterly losses of $(0.23) per share which missed the analyst consensus estimate of $(0.22) by 4.55 percent.

ATYR

aTyr Pharma Q3 2024 GAAP EPS $(0.23) Misses $(0.22) Estimate

Spyre Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SYRE#NASDAQ">SYRE</a>) reported quarterly losses of $(1.36) per share which missed the analyst consensus estimate of $(0.83) by 63.86 percent. This is a 85.44 percent increase over losses of $(9.34) per share from the same period last year.

SYRE

Spyre Therapeutics Q3 EPS $(1.36) Misses $(0.83) Estimate

Myriad Genetics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MYGN#NASDAQ">MYGN</a>) raises FY2024 Adj EPS guidance from $0.08-0.12 to $0.12-0.14 vs $0.10 analyst estimate. Narrows FY2024 sales outlook from $835.00 million-845.00 million to $837.00 million-843.00 million vs $841.44 million estimate.

Guidance

MYGN

Myriad Genetics Raises FY2024 Adj EPS Guidance from $0.08-0.12 to $0.12-0.14 vs $0.10 Est; Narrows FY2024 Sales Guidance from $835.00M-845.00M to $837.00M-843.00M vs $841.44M Est

LCUT

Lifetime Brands shares are trading lower after the company reported worse-than-expected Q3 financial results and lowered its FY24 guidance and Q4 EPS guidance.

SLDP

Solid Power Continues To Expect 2024 Revenue Of $16M - $20M, Est $19.783M

HeartBeam (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BEAT#NASDAQ">BEAT</a>) reported quarterly losses of $(0.19) per share which missed the analyst consensus estimate of $(0.17) by 11.76 percent.

BEAT

HeartBeam Q3 2024 GAAP EPS $(0.19) Misses $(0.17) Estimate

US Global Investors (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GROW#NASDAQ">GROW</a>) reported quarterly earnings of $0.02 per share. This is a 300 percent increase over losses of $(0.01) per share from the same period last year. The company reported $2.16 million in sales this quarter. This is a 31.15 percent decrease over sales of $3.13 million the same period last year.

GROW

US Global Investors Q1 EPS $0.02 Up From $(0.01) YoY, Sales $2.16M Down From $3.13M YoY

Innovex International (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/INVX#NYSE">INVX</a>) reported quarterly earnings of $0.25 per share which met the analyst consensus estimate. This is a 47.92 percent decrease over earnings of $0.48 per share from the same period last year. The company reported quarterly sales of $151.82 million which beat the analyst consensus estimate of $135.00 million by 12.46 percent. This is a 9.15 percent increase over sales of $139.09 million the same period last year.

INVX

Innovex International Q3 Adj $0.25, Inline, Sales $151.82M Beat $135.00M Estimate

Eventbrite (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EB#NYSE">EB</a>) sees Q4 sales of $74.000 million-77.000 million vs $75.47 million estimate.

Eventbrite Sees Q4 Sales $74.000M-77.000M vs $75.47M Est

Tectonic Therapeutic (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TECX#NASDAQ">TECX</a>) reported quarterly losses of $(1.20) per share which missed the analyst consensus estimate of $(0.84) by 42.86 percent.

TECX

Tectonic Therapeutic Q3 2024 GAAP EPS $(1.20) Misses $(0.84) Estimate

Li-Cycle Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LICY#NYSE">LICY</a>) reported quarterly earnings of $2.15 per share which beat the analyst consensus estimate of $(1.32) by 262.88 percent. This is a 241.45 percent increase over losses of $(1.52) per share from the same period last year. The company reported quarterly sales of $8.40 million which beat the analyst consensus estimate of $6.98 million by 20.34 percent. This is a 78.72 percent increase over sales of $4.70 million the same period last year.

LICY

Li-Cycle Holdings Q3 EPS $2.15 Beats $(1.32) Estimate, Sales $8.40M Beat $6.98M Estimate

Definitive Healthcare (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DH#NASDAQ">DH</a>) reported quarterly earnings of $0.10 per share which beat the analyst consensus estimate of $0.08 by 25 percent. This is a 11.11 percent increase over earnings of $0.09 per share from the same period last year. The company reported quarterly sales of $62.70 million which beat the analyst consensus estimate of $61.72 million by 1.58 percent. This is a 4.02 percent decrease over sales of $65.33 million the same period last year.

Definitive Healthcare Q3 Adj $0.10 Beats $0.08 Estimate, Sales $62.70M Beat $61.72M Estimate

MeridianLink (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MLNK#NYSE">MLNK</a>) reported quarterly earnings of $0.06 per share which missed the analyst consensus estimate of $0.08 by 25 percent. The company reported quarterly sales of $80.369 million which beat the analyst consensus estimate of $79.969 million by 0.50 percent. This is a 5.07 percent increase over sales of $76.488 million the same period last year.

MLNK

MeridianLink Q3 2024 Adj. EPS $0.06 Misses $0.08 Estimate, Sales $80.369M Beat $79.969M Estimate

Boundless Bio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BOLD#NASDAQ">BOLD</a>) reported quarterly losses of $(0.74) per share which beat the analyst consensus estimate of $(0.82) by 9.76 percent.

BOLD

Boundless Bio Q3 2024 GAAP EPS $(0.74) Beats $(0.82) Estimate

Sports betting and iGaming company DraftKings Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DKNG#NASDAQ">DKNG</a>) reported third-quarter financial results<a href="https://www.benzinga.com/earnings"> after market close Thursday.</a>
Here are the key highlights.
What Happened: DraftKings reported third-quarter revenue of $1.095 billion, up 39% year-over-year. The revenue total missed a Street consensus estimate of $1.112 billion according to data <a href="https://www.benzinga.com/pro/?utm_source=BZprocontent110724&amp;t=be2bearmibe3na1">from Benzinga Pro.</a>
The company said revenue growth came from strong customer engagement, the acquisition of new customers, the launch in new territories, and the impact of the acquisition of Jackpocket, which closed in May.
The company reported a loss of 17 cents per share, which beat a Street consensus estimate of a loss of 42 cents per share.
Monthly unique payers (MUP) were 3.6 million in the third quarter, up 55% year-over-year. Excluding the impact of the Jackpocket acquisition, monthly unique payers would have been up 27% year-over-year.
The average revenue per MUP was $103 in the third quarter, down 10% year over year. The lower revenue per payer was due to the Jackpocket acquisition. Excluding the Jackpocket acquisition, the average revenue per MUP was 8% higher year over year.
"DraftKings delivered strong performance in the third quarter with the return of NFL and college football," DraftKings CEO Jason Robins said.
DraftKings was live for mobile sports betting in 25 states and Washington D.C., representing 49% of the U.S. population in the third quarter. The company is also live with iGaming in five states and live for both sportsbook and iGaming in Ontario, Canada.
Read Also: <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/11/41792879/draftkings-q3-earnings-highlights-nfl-in-focus-will-missouri-legalization-factor-in">DraftKings Q3 Earnings Preview: NFL In Focus, Will Missouri Legalization Factor Into Guidance?</a>
What's Next: The company lowered its fiscal year 2024 revenue guidance from a range of $5.05 billion to $5.25 billion to a new range of $4.85 billion to $4.95 billion due to customer-friendly sport outcomes in the fourth quarter, which comes with the NFL season having several weeks of favorable outcomes for bettors.
Analysts expect the company to report revenue of $5.14 billion for the full fiscal year, according to data from Benzinga Pro.
The company also revised its 2024 adjusted EBITDA guidance from a range of $340 million to $420 million to a new range of $240 million to $280 million.
DraftKings introduced fiscal year 2025 revenue guidance for the first time, with a range of $6.2 billion to $6.6 billion expected. The company also said it expects 2025 adjusted EBITDA to be in a range of $900 million to $1.0 billion, reaffirming guidance from August.
"With major sports converging on the calendar, we are well-positioned to build on this momentum as we further enhance our top-ranked sportsbook app with additional live betting features and exciting new NBA markets," Robins said. "Our focus remains on driving sustainable revenue growth and profitability in 2025 and beyond."
The company's 2024 and 2025 guidance includes all existing mobile sports betting and iGaming markets and Jackpocket, but does not include any pending state launches.
Missouri legalized sports betting on Election Day 2024 and DraftKings expects to launch its sportsbook in the state pending approval. The company also expects to launch its sportsbook in Puerto Rico, which is pending approval.
DKNG Price Action: DraftKings stock is down 5% to $37.00 in after-hours trading Thursday, versus a 52-week trading range of $28.69 to $49.57.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/general/politics/24/11/41725070/draftkings-offers-10k-in-prizes-for-2024-election-predictions-harris-trump-swing-state-performan">DraftKings Offers $10K In Prizes For 2024 Election Predictions: Harris, Trump Swing State Performance Among Key Questions</a></li>
</ul>
Photo: Shutterstock

Sports Betting

Movers

Trading Ideas

DKNG

DraftKings Q3 Highlights: Revenue Miss, 2024 Guidance Trim, First 2025 Outlook, CEO Reaffirms Focus On 'Sustainable Revenue Growth'

QRHC

Quest Resources shares are trading higher after the company reported better-than-expected Q3 adjusted EPS results.

Eventbrite (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EB#NYSE">EB</a>) reported quarterly losses of $(0.04) per share which beat the analyst consensus estimate of $(0.13) by 69.23 percent. This is a 60 percent increase over losses of $(0.10) per share from the same period last year. The company reported quarterly sales of $77.80 million which beat the analyst consensus estimate of $75.83 million by 2.60 percent. This is a 4.59 percent decrease over sales of $81.54 million the same period last year.

Eventbrite Q3 EPS $(0.04) Beats $(0.13) Estimate, Sales $77.80M Beat $75.83M Estimate

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
In late July, Conn&rsquo;s (OTCMKTS:<a href="https://investorplace.com/stock-quotes/connq-stock-quote/">CONNQ</a>) <a href="https://www.usatoday.com/story/money/retail/2024/07/25/conns-homeplus-bankruptcy-closing-stores-list/74538801007/">announced</a> that it filed for Chapter 11 and would close at least 70 locations across 13 states. It quickly was added to a list of <a href="https://investorplace.com/industries/consumer-discretionary/retail/">retail stocks</a> to sell. Its shares now trade over the counter, down nearly 99% year-to-date.&nbsp;



Fast forward to August. It is now closing all 174 of its stores across 15 states. With the store closures from its December 2023 acquisition of Badcock &amp; More, it will close more than <a href="https://www.goodhousekeeping.com/life/money/a61751825/conns-homeplus-store-closures-by-state/">500 stores</a>.&nbsp;




&ldquo;Conn&rsquo;s and Badcock have served as a go-to destination for its loyal customers&rsquo; home goods necessities for more than a century,&rdquo; said Tim Shilling, president of B. Riley Retail Solutions, which is hosting the liquidation.




How does a retailer acquire in December and then go bankrupt in July? Unfortunately, it&rsquo;s all too common in retail.&nbsp;



Who else could go bankrupt in 2024? Here are three retailers at the top of my list of retail stocks to sell for this very reason.&nbsp;



<h2>The RealReal (REAL)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2021/12/luxury-stocks-300x169.jpg" alt="Handsome stylish man in beige suit at home sitting on sofa; luxury goods and experience stocks. global stocks to buy"><div>Source: 4 PM production / Shutterstock.com</div></div>The RealReal (NASDAQ:<a href="https://investorplace.com/stock-quotes/real-stock-quote/">REAL</a>) is the smallest of the three retail stocks to sell, with a market capitalization of $262 million.&nbsp;



The San Francisco-based online marketplace for buyers and sellers of resale luxury goods had a Q2 2024 GMV (gross merchandise value) increase of 4% year-over-year, leading to net revenue of $145 million, 11% higher than in 2023, with an adjusted EBITDA loss of $1.8 million, down from a $22.3 million loss in Q2 2023.&nbsp;



There is no question that its business will be stronger in 2024.&nbsp;



However, according to GuruFocus.com, its Altman Z-Score is <a href="https://www.gurufocus.com/term/zscore/REAL">-3.06</a>. The Altman Z-Score predicts the likelihood of bankruptcy proceedings within the next 24 months. Generally, you want this figure to be 1.81 or higher, out of the distress zone.&nbsp;



As of Q2 2024, its net debt was $402.3 million or 154% of its market cap.&nbsp;



That&rsquo;s based on total debt of <a href="https://investor.therealreal.com/static-files/10a7cf5d-4047-43c0-9a10-dcd2759441a7">$553.2 million</a> [operating lease liabilities: current $22.1 million and long-term $97.0 million plus non-convertible notes $131.3 million, convertible senior notes of $276.2 million, and current portion convertible senior notes $26.6 million] less cash and cash equivalents of $150.7 million.



Given that its annualized interest expense in 2024 should be approximately $23 million&mdash;Q2 2024 interest expense of $5.8 million times four quarters&mdash;it can ill afford to lose momentum on its turnaround.&nbsp;



<h2>Petco Health &amp; Wellness (WOOF)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2020/12/woof-stock-1-300x169.jpg" alt="The front of a Petco (WOOF) store in Los Angeles, California."><div>Source: Walter Cicchetti / Shutterstock.com</div></div>Petco Health &amp; Wellness (NASDAQ:<a href="https://investorplace.com/stock-quotes/woof-stock-quote/">WOOF</a>) stock rallied 27% in late May after delivering a <a href="https://www.marketwatch.com/story/petcos-stock-soars-12-premarket-after-narrower-than-expected-loss-as-ceo-says-company-on-track-for-return-to-profit-074535a5">Q1 2024</a> loss of four cents, two cents better than the analyst estimate. On the top line, its sales were down 2% to $1.53 billion, but $16 million higher than the Wall Street estimate.&nbsp;



Like RealReal, it&rsquo;s in the middle of transforming the business for sustained and profitable growth. Despite the better news, Petco is <a href="https://www.marketwatch.com/investing/stock/woof/analystestimates">expected to lose</a> four cents a share in 2024 and turn profitable in 2025.&nbsp;



The problem is that Petco&rsquo;s Altman Z-Score is <a href="https://www.gurufocus.com/term/zscore/WOOF">0.18</a>, well below 1.81, the level at which a company moves from the distressed zone. It could still go bankrupt in the next 24 months.



Its biggest issue is debt. As of May 4, it had <a href="https://www.morningstar.com/stocks/xnas/woof/financials">$2.98 billion</a> in total debt at the end of Q1 2025 and less than $90 million in cash. Its net debt of $2.89 billion is 3.6x its current market cap.&nbsp;&nbsp;&nbsp;&nbsp;



Its hiring of Joel Anderson as CEO in mid-July&mdash;Anderson ran Five Below (NASDAQ:<a href="https://investorplace.com/stock-quotes/five-stock-quote/">FIVE</a>) for <a href="https://www.investopedia.com/petco-stock-rises-after-hiring-new-ceo-five-below-8679865">nearly a decade</a>&mdash;might be too late to save Petco.&nbsp;&nbsp;



<h2>Nordstrom (JWN)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2019/08/nordstrom_jwn_stock_jwn1600-300x169.jpg" alt="A Nordstrom (JWN) storefront in Toronto, Canada."><div>Source: Jonathan Weiss / Shutterstock.com</div></div>Nordstrom (NYSE:<a href="https://investorplace.com/stock-quotes/jwn-stock-quote/">JWN</a>) is the largest of the three retail stocks with a market cap of $3.55 billion. Its stock is up more than 18% in 2024 but down 26% over the past five years.&nbsp;



Nordstrom&rsquo;s Altman Z-Score is right on the fence at <a href="https://www.gurufocus.com/term/zscore/JWN#:~:text=Nordstrom%20has%20a%20Altman%20Z,company%20may%20face%20bankrupcy%20risk.">1.82</a>, just outside the distressed zone. I&rsquo;ve included the department store chain because of its total debt. As of Q1 2025, it was <a href="https://companiesmarketcap.com/nordstrom/total-debt/#:~:text=Total%20debt%20on%20the%20balance,total%20debt%20is%20%244.23%20B.">$4.2</a>3<a href="https://companiesmarketcap.com/nordstrom/total-debt/#:~:text=Total%20debt%20on%20the%20balance,total%20debt%20is%20%244.23%20B."> billion</a>, nearly 1.2x its market cap. Excluding cash, it has a net debt of $3.81 billion or 45% of its total assets.&nbsp;



Nordstrom&rsquo;s short interest is currently 14.96 million shares, accounting for <a href="https://www.barrons.com/market-data/stocks/jwn">13.72%</a> of its float. By comparison, Walmart&rsquo;s (NYSE:<a href="https://investorplace.com/stock-quotes/wmt-stock-quote/">WMT</a>) short interest rate is <a href="https://www.barrons.com/market-data/stocks/wmt?mod=searchresults_companyquotes&amp;mod=searchbar&amp;search_keywords=WMT&amp;search_statement_type=suggested">0.85%</a>, considerably less than Nordstrom&rsquo;s. While it doesn&rsquo;t make the list of stocks whose floats are most shorted &mdash; it starts at <a href="https://www.marketwatch.com/tools/screener/short-interest">28%</a> &mdash; it is something to be aware of.&nbsp;



What investors often forget is that total debt includes not only the loans a retail company has outstanding but also the leases it&rsquo;s committed to for its store locations. Those are future obligations to meet.&nbsp;



As I said, I don&rsquo;t believe you&rsquo;ll see Nordstrom in bankruptcy court anytime soon. However, its adjusted return on invested capital remains low at <a href="https://investor.nordstrom.com/static-files/4929cd7e-c259-4dba-a327-2b3fd353d05f">8.2%</a>, less than half what it was <a href="https://www.morningstar.com/stocks/xnys/jwn/performance">five years ago</a>.&nbsp;



There are much better retail stocks to own.&nbsp;



On the date of publication, Will Ashworth did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/"> Publishing Guidelines</a>.



On the date of publication, the responsible editor did not have (either directly or indirectly) any positions in the securities mentioned in this article.&nbsp;
<div>Will Ashworth has written about investments full-time since 2008. Publications where he&rsquo;s appeared include InvestorPlace, The Motley Fool Canada, Investopedia, Kiplinger, and several others in both the U.S. and Canada. He particularly enjoys creating model portfolios that stand the test of time. He lives in Halifax, Nova Scotia.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul>
The post <a href="https://investorplace.com/2024/08/3-retail-stocks-to-sell-before-they-hit-the-bankruptcy-bin/">3 Retail Stocks to Sell Before They Hit the Bankruptcy Bin </a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Comments

Conn's

Notizie

Ultime notizie per Conn's (OTC:CONNQ) Azioni

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO